Sanderling Venture Partners VI LP

Average Profitability
33.11%
Insider Buys Quantity
2
Insider Buys Sum
$6.27M
Insider Sells Quantity
5
Insider Sells Sum
$32.43M

Insider Activity of Sanderling Venture Partners VI LP

According to the SEC Form 4 filings, Sanderling Venture Partners VI LP, being in a position of

  1. 10 percent owner at CalciMedica, Inc.,
    оver the last 12 months, has bought 679384 shares for $2.52M, and sold 0 shares,
    over all time since 2024-01-23, has bought 679384 shares for $2.52M, and sold 0 shares.

The largest purchase of all time was on 2011-02-08 and amounted to 535714 shares of Pacira BioSciences, Inc. for $3.75M.

The largest sale of all time was on 2013-03-11 and amounted to 348951 share of Pacira BioSciences, Inc. for $9.72M.

Biography of Sanderling Venture Partners VI LP

No biography is available at this moment.

2024-01-23PurchaseCalciMedica, Inc.
CALC
10 percent owner
679,384
5.4073%
$3.70$2.52M-22.14%
2013-03-19SalePacira BioSciences, Inc.
PCRX
director
169,178
0.5214%
$27.27$4.61M+50.91%
2013-03-18SalePacira BioSciences, Inc.
PCRX
director
276,719
0.8611%
$28.78$7.97M+44.02%
2013-03-11SalePacira BioSciences, Inc.
PCRX
10 percent owner
348,951
1.0151%
$27.86$9.72M+28.59%
2013-03-07SalePacira BioSciences, Inc.
PCRX
10 percent owner
25,560
0.0776%
$25.92$662,515+42.72%
2013-01-24SalePacira BioSciences, Inc.
PCRX
10 percent owner
500,000
1.4534%
$18.93$9.46M+73%
2011-02-08PurchasePacira BioSciences, Inc.
PCRX
10 percent owner
535,714
5.5725%
$7.00$3.75M+33.11%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.